"Li-Fraumeni syndrome is a hereditary cancer syndrome due to mutations in the tumour suppressor gene TP53. Approximately half of affected individuals are thought to develop invasive cancer by 30 years of age 1."
"The incidence of Li-Fraumeni syndrome (LFS), is approximately 1 in 5,000 to 1 in 20,000 individuals, around 0.8% or more in unselected paediatric cancer patients, and up to 10.4% among children whose tumours harbour TP53 variants."
"Treatment and Prognosis"
"The disorder was described in 1969 by the cancer geneticists Frederick Li and Joseph Fraumeni, Jr, who were then working at the National Cancer Institute in Maryland, USA 2."
Expected headings
"Treatment and Prognosis"
"adrenocortical carcinoma (ACC) - 50-80% of ACCs presenting in childhood are linked to LFS; children often present with virilisation or Cushing syndrome"
"42% of individuals with Li-Fraumeni syndrome die from cancer; most of these individuals die before age 60 5"
"History and etymology"